1. Home
  2. EARN vs STXS Comparison

EARN vs STXS Comparison

Compare EARN & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EARN
  • STXS
  • Stock Information
  • Founded
  • EARN 2012
  • STXS 1990
  • Country
  • EARN United States
  • STXS United States
  • Employees
  • EARN N/A
  • STXS N/A
  • Industry
  • EARN Real Estate Investment Trusts
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • EARN Real Estate
  • STXS Health Care
  • Exchange
  • EARN Nasdaq
  • STXS Nasdaq
  • Market Cap
  • EARN 223.5M
  • STXS 261.1M
  • IPO Year
  • EARN 2013
  • STXS 2004
  • Fundamental
  • Price
  • EARN $5.64
  • STXS $2.85
  • Analyst Decision
  • EARN Buy
  • STXS
  • Analyst Count
  • EARN 2
  • STXS 0
  • Target Price
  • EARN $6.13
  • STXS N/A
  • AVG Volume (30 Days)
  • EARN 299.3K
  • STXS 395.1K
  • Earning Date
  • EARN 11-11-2025
  • STXS 11-10-2025
  • Dividend Yield
  • EARN 17.02%
  • STXS N/A
  • EPS Growth
  • EARN N/A
  • STXS N/A
  • EPS
  • EARN N/A
  • STXS N/A
  • Revenue
  • EARN $35,893,000.00
  • STXS $31,806,000.00
  • Revenue This Year
  • EARN $3.72
  • STXS $30.92
  • Revenue Next Year
  • EARN $18.59
  • STXS $43.27
  • P/E Ratio
  • EARN N/A
  • STXS N/A
  • Revenue Growth
  • EARN 43.30
  • STXS 33.94
  • 52 Week Low
  • EARN $4.33
  • STXS $1.54
  • 52 Week High
  • EARN $7.11
  • STXS $3.05
  • Technical
  • Relative Strength Index (RSI)
  • EARN 43.69
  • STXS 56.73
  • Support Level
  • EARN $5.56
  • STXS $2.81
  • Resistance Level
  • EARN $5.70
  • STXS $2.92
  • Average True Range (ATR)
  • EARN 0.08
  • STXS 0.11
  • MACD
  • EARN -0.01
  • STXS -0.01
  • Stochastic Oscillator
  • EARN 24.85
  • STXS 62.07

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics, and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: